Search

Home > JACC Podcast > Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy | JACC
Podcast: JACC Podcast
Episode:

Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy | JACC
Category: Health
Duration: 00:12:05
Publish Date: 2025-03-10 14:00:00
Description:

In this episode, Dr. Valentin Fuster highlights a groundbreaking study on acoramides, a novel treatment for transthyretin amyloid cardiomyopathy (ATTR), which shows significant reductions in mortality and cardiovascular hospitalizations compared to a placebo. Experts discuss the clinical implications, comparing acoramides to the previously approved tafamidis, noting exciting advancements in treatments for a once-untreatable disease.
Total Play: 0

Some more Podcasts by American College of Cardiology

500+ Episodes
JACC: Clinic .. 10+     1
1K+ Episodes
JACC's Audio .. 70+     10+